Skip to main content
Equibles

Corient Private Wealth LLC

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1948780 MIAMI, FL
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 27, 2026
Position Value
$4,891,401
+$2,030,805 QoQ
Shares Held
146,493
+7.3% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#90
of 311 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Corient Private Wealth LLC holds $248,190,588 across 122 Biotechnology names. RARE ranks #11 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 103,755 $51,538,220
2 IONS
Ionis Pharmaceuticals Inc
 196,661 $15,593,250
3 HALO
Halozyme Therapeutics, Inc.
 187,166 $14,649,482
4 KRYS
Krystal Biotech, Inc.
 30,558 $11,357,491
5 TECH
BIO-TECHNE Corp
 119,590 $8,449,033
6 REGN
Regeneron Pharmaceuticals, Inc.
 12,473 $7,777,414
7 ALNY
Alnylam Pharmaceuticals, Inc.
 23,969 $7,215,387
8 CLDX
Celldex Therapeutics, Inc.
 176,956 $6,584,532

All Filings in RARE

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,891,401 146,493
2026-03-31 $2,860,596 136,544